Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Ben Davidson. (2019) Biomarkers of drug resistance in ovarian cancer – an update. Expert Review of Molecular Diagnostics 19:6, pages 469-476.
Read now
Read now
Articles from other publishers (25)
Yan Li, Juan Wang, Fang Wang, Chengzhen Gao, Yuanyuan Cao & Jianhua Wang. (2021) Identification of Specific Cell Subpopulations and Marker Genes in Ovarian Cancer Using Single-Cell RNA Sequencing. BioMed Research International 2021, pages 1-27.
Crossref
Crossref
Rachael Jean Rodgers, Jason Anthony Abbott, Kirsty A. Walters & William Leigh Ledger. (2021) Translational Physiology of Anti-Müllerian Hormone: Clinical Applications in Female Fertility Preservation and Cancer Treatment. Frontiers in Endocrinology 12.
Crossref
Crossref
Qipeng Fan, Lihong Li, Tian-Li Wang, Robert E. Emerson & Yan Xu. (2021) A Novel ZIP4-HDAC4-VEGFA Axis in High-Grade Serous Ovarian Cancer. Cancers 13:15, pages 3821.
Crossref
Crossref
Zeba Mueed, Pankaj Kumar Rai, Seemab Siddique & Nitesh Kumar Poddar. (2021) Ovarian Cancer Biomarkers: Headway Towards Early Diagnosis. Current Chemical Biology 15:1, pages 109-125.
Crossref
Crossref
Ben Davidson, Arild Holth & Hiep Phuc Dong. (2020) Expression of the cancer stem cell marker SSEA1 is associated with poor survival in metastatic high-grade serous carcinoma. Virchows Archiv 477:5, pages 677-685.
Crossref
Crossref
Caihua Dong, Fuqiang Yin, Dan Zhu, Xiangxue Cai, Cuilan Chen & Xia Liu. (2020) NCALD affects drug resistance and prognosis by acting as a ceRNA of CX3CL1 in ovarian cancer. Journal of Cellular Biochemistry 121:11, pages 4470-4483.
Crossref
Crossref
Marta Brunetti, Ioannis Panagopoulos, Ilyá Kostolomov, Ben Davidson, Sverre Heim & Francesca Micci. (2020) Mutation analysis and genomic imbalances of cells found in effusion fluids from patients with ovarian cancer. Oncology Letters 20:3, pages 2273-2279.
Crossref
Crossref
Esther Channah Broner, Hadil Onallah, Tali Tavor Re’em, Ben Davidson & Reuven Reich. (2020)
Role of the Exosome Secretion Machinery in Ovarian Carcinoma:
In Vitro
and
In Vivo
Models
. Journal of Oncology 2020, pages 1-11.
Crossref
Crossref
Miriam Sherman-Samis, Hadil Onallah, Arild Holth, Reuven Reich & Ben Davidson. (2019) SOX2 and SOX9 are markers of clinically aggressive disease in metastatic high-grade serous carcinoma. Gynecologic Oncology 153:3, pages 651-660.
Crossref
Crossref
Tzu-Pin Lu, Kuan-Ting Kuo, Ching-Hsuan Chen, Ming-Cheng Chang, Hsiu-Ping Lin, Yu-Hao Hu, Ying-Cheng Chiang, Wen-Fang Cheng & Chi-An Chen. (2019) Developing a Prognostic Gene Panel of Epithelial Ovarian Cancer Patients by a Machine Learning Model. Cancers 11:2, pages 270.
Crossref
Crossref
Karine Flem Karlsen, Erin McFadden, Vivi Ann Flørenes & Ben Davidson. (2019) Soluble AXL is ubiquitously present in malignant serous effusions. Gynecologic Oncology 152:2, pages 408-415.
Crossref
Crossref
Marta Brunetti, Arild Holth, Ioannis Panagopoulos, Anne Cathrine Staff, Francesca Micci & Ben Davidson. (2018) Expression and clinical role of the dipeptidyl peptidases DPP8 and DPP9 in ovarian carcinoma. Virchows Archiv 474:2, pages 177-185.
Crossref
Crossref
Xiaoling Tian, Wencai Guan, Lingyun Zhang, Wenwen Sun, Daibing Zhou, Qunbo Lin, Weimin Ren, Lubna Nadeem & Guoxiong Xu. (2018) Physical interaction of STAT1 isoforms with TGF-β receptors leads to functional crosstalk between two signaling pathways in epithelial ovarian cancer. Journal of Experimental & Clinical Cancer Research 37:1.
Crossref
Crossref
Hadil Onallah, Liora Jacobs Catane, Claes G. Tropé, Thea E. Hetland Falkenthal, Reuven Reich & Ben Davidson. (2018) Activity and clinical relevance of autotaxin and lysophosphatidic acid pathways in high-grade serous carcinoma. Virchows Archiv 473:4, pages 463-470.
Crossref
Crossref
Ben Davidson, Marianne Bjørnerem, Arild Holth, Ellen Hellesylt, Thea E. Hetland Falkenthal & Vivi Ann Flørenes. (2018) Expression, activation and clinical relevance of CHK1 and CHK2 in metastatic high-grade serous carcinoma. Gynecologic Oncology 150:1, pages 136-142.
Crossref
Crossref
Brian Z. Ring, Rajmohan Murali, Robert A. Soslow, David D.L. Bowtell, Sian Fereday, Anna deFazio, Nadia Traficante, Catherine J. Kennedy, Alison Brand, Raghwa Sharma, Paul Harnett & Goli Samimi. (2018) Transducin-Like Enhancer of Split 3 (TLE3) Expression Is Associated with Taxane Sensitivity in Nonserous Ovarian Carcinoma in a Three-Cohort Study. Cancer Epidemiology, Biomarkers & Prevention 27:6, pages 680-688.
Crossref
Crossref
Juliana A. Josahkian, Fabiano Pinto Saggioro, Thiago Vidotto, Henrique Torres Ventura, Francisco José Candido dos Reis, Christiani Bisinoto de Sousa, Daniel Guimarães Tiezzi, Jurandyr Moreira de Andrade, Madhuri Koti & Jeremy A. Squire. (2018) Increased STAT1 Expression in High Grade Serous Ovarian Cancer Is Associated With a Better Outcome. International Journal of Gynecologic Cancer 28:3, pages 459-465.
Crossref
Crossref
Chutima Kaewpiboon, Nawong Boonnak, Sirichat Kaowinn & Young-Hwa Chung. (2018) Formoxanthone C, isolated from Cratoxylum formosum ssp. pruniflorum, reverses anticancer drug resistance by inducing both apoptosis and autophagy in human A549 lung cancer cells. Bioorganic & Medicinal Chemistry Letters 28:4, pages 820-825.
Crossref
Crossref
Ben Davidson. 2018. Serous Effusions. Serous Effusions
191
237
.
Hamid Moradi, Abrar Ahmad, Dean Shepherdson, Nhung H. Vuong, Gosia Niedbala, Libni Eapen, Barbara Vanderhyden, Balazs Nyiri & Sangeeta Murugkar. (2017) Raman micro-spectroscopy applied to treatment resistant and sensitive human ovarian cancer cells. Journal of Biophotonics 10:10, pages 1327-1334.
Crossref
Crossref
Wenming Liu, Chunping Lv, Bin Zhang, Quansheng Zhou & Zhifei Cao. (2017)
MicroRNA-27b functions as a new inhibitor of ovarian cancer-mediated vasculogenic mimicry through suppression of
VE-cadherin
expression
. RNA 23:7, pages 1019-1027.
Crossref
Crossref
Keren Harel-Dassa, Saul Yedgar, Claes G. Tropé, Ben Davidson & Reuven Reich. (2017) Phospholipase D messenger RNA expression and clinical role in high-grade serous carcinoma. Human Pathology 62, pages 115-121.
Crossref
Crossref
Esther Channah Broner, Claes G. Tropé, Reuven Reich & Ben Davidson. (2017) TSAP6 is a novel candidate marker of poor survival in metastatic high-grade serous carcinoma. Human Pathology 60, pages 180-187.
Crossref
Crossref
Ben Davidson. (2016) CD24 is highly useful in differentiating high-grade serous carcinoma from benign and malignant mesothelial cells. Human Pathology 58, pages 123-127.
Crossref
Crossref
Soozana Puvanenthiran, Sharadah Essapen, Alan M. Seddon & Helmout Modjtahedi. (2016) Impact of the putative cancer stem cell markers and growth factor receptor expression on the sensitivity of ovarian cancer cells to treatment with various forms of small molecule tyrosine kinase inhibitors and cytotoxic drugs. International Journal of Oncology 49:5, pages 1825-1838.
Crossref
Crossref